GlassScriptPhysician profile
Divya M Chalikonda
NPI 1124473921
$2,980.47
in general payments reported to CMS, 2019-2025
11 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $144 · 2021: $87.66 · 2022: $125 · 2023: $1,056 · 2024: $1,380 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386 · Travel and Lodging: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,386.16 |
| Travel and Lodging | $237.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,184.90 | 2020-2024 | Resolution 360 Clip, Spyglass, Exalt Model D |
| Medtronic, INC. | $557.23 | 2022-2024 | Gi Genius |
| Conmed Corporation | $379.24 | 2023-2025 | Conmed Biliary, Conmed Generators, Conmed Dilation |
| Cook Medical LLC | $350.36 | 2024 | Hemospray, Echotip Insight |
| Janssen Biotech, INC. | $253.96 | 2020-2022 | |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.63 | 2023 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.55 | 2022 | |
| Olympus America INC. | $16.56 | 2024 | Evis X1 Video System Center |
| Amgen INC. | $14.53 | 2025 | Uplizna |
| Phathom Pharmaceuticals, INC. | $13.51 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Chalikonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.